甲氟喹1989年被美国FDA列为预防和治疗耐氯隆及对氯喹敏感的恶性疟原虫和间日疟原虫引起的感染。目前，该药已成为旅行者预防耐氯险及对甲氟喹敏感疟疾的选择性药物。约47％患者产生不良反应，但一般轻微（包括胃肠道紊乱、眩晕及头痛），严重不良反应罕见。本文报道1例接受甲? Mefloquine was the FDA in the United States in 1989 for the prevention and treatment of resistance to chloro-chloroquine and chloroquine-sensitive infections caused by Plasmodium falciparum and Plasmodium vivax. Currently, the drug has become a traveler’s choice of drug for the prevention of chlorine-resistant and nifedipine-sensitive malaria. About 47% of patients have adverse reactions, but generally mild (including gastrointestinal disorders, dizziness and headache), serious adverse reactions rare. This article reports 1 case accepted A?